Strand Therapeutics is a biotechnology company that develops innovative therapies using messenger RNA (mRNA) technology. The company's proprietary platform enables the design of mRNA therapeutics that can target specific cells and tissues, providing a potential treatment for a wide range of diseases. Strand's lead program is focused on developing mRNA therapies for cancer, with a goal of creating personalized treatments that can be tailored to individual patients. The company was founded in 2016 and is headquartered in Cambridge, MA.